EUVIMEDEUVIMED entdecken
Crossref

Can Quercetin protect against the pre-disposing factors for Alzheimer’s disease via inhibiting NLRP3 inflammasome pathway?

Azza S Awad iD, Bassant M El-Mokadem, Miar M Sherif, Abeer Bishr

Journal of Pharmacy and Pharmacology · 2025

DOI: 10.1093/jpp/rgaf020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Azza S Awad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy (Girls), Al-Azhar University, Nasr city, Cairo, Egypt. Hauptthemen laut MEDLINE: Quercetin, Alzheimer Disease, NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The brain and its cognitive functions are most liable to stress, where it is known to promote the pathological manifestation of Alzheimer’s disease (AD). This study aimed to investigate the effect of a 2-week-period of restraint stress (RS), as well as the protective effect of Quercetin in a dose-dependent manner against the early start of AD via studying the NLRP3 inflammasome pathway.

Methods

The rats were divided into four groups: control (Con), induction (Ind), where 6 h/day for 2 weeks of RS was induced, low and high doses of Q (Q1+Ind and Q2+Ind, respectively), which were administered before the induction of RS for the same period. Behavioral tests were performed to assess the cognitive functions. Key findings The higher dose of Q has shown more inhibition of the NLRP3 inflammasome pathway, oxidative stress, as well as the phosphorylated-tau and amyloid-β (Aβ) protein, which were significantly fired up by the 2 weeks of RS. These results were backed with the improved cellular structure in the histopathological examination and enhanced cognitive functions, where the two doses of Q have shown their protective effect.

Conclusions

This proves that Q shielded the brain against the initial pathogenesis of AD, induced by 2 weeks of RS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuercetinAlzheimer DiseaseNLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesAnimalsMaleOxidative StressAmyloid beta-PeptidesRatstau ProteinsBrainCognitionDose-Response Relationship, DrugDisease Models, AnimalStress, PsychologicalSignal TransductionAntioxidantsRats, Wistar

Stichwörter der Autor:innen

Alzheimer’s diseaseAβNLRP3NSEtau protein

Substanzen

QuercetinNLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesAmyloid beta-PeptidesNlrp3 protein, rattau ProteinsAntioxidants

Autor:innen und Institutionen

  • Faculty of Pharmacy (Girls), Al-Azhar University, Nasr city, Cairo, Egypt.
  • Faculty of Pharmacy, Ahram Canadian University, Egypt.
  • Egyptian Drug Authority (EDA), Egypt.

ORCID-Profile: Azza S Awad

Zitieren

APA

Awad, A. S., El-Mokadem, B. M., Sherif, M. M., & Bishr, A. (2025). Can Quercetin protect against the pre-disposing factors for Alzheimer’s disease via inhibiting NLRP3 inflammasome pathway?. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf020

Vancouver

Awad AS, El-Mokadem BM, Sherif MM, Bishr A. Can Quercetin protect against the pre-disposing factors for Alzheimer’s disease via inhibiting NLRP3 inflammasome pathway?. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgaf020

BibTeX
@article{Awad2025,
  author = {Awad, Azza S and El-Mokadem, Bassant M and Sherif, Miar M and Bishr, Abeer},
  title = {Can Quercetin protect against the pre-disposing factors for Alzheimer’s disease via inhibiting NLRP3 inflammasome pathway?},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2025},
  doi = {10.1093/jpp/rgaf020}
}
Kostenlos starten →